Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Articles|September 20, 2007
ICAAC: Day-Care Safer Thanks To Vaccines
Author(s)Michael Smith
This MedPage Today video features senior staff writer Michael Smith sitting down with Larry Pickering, M.D., an infectious diseases specialist at the CDC, and Janet Englund, M.D., of the University of Washington in Seattle, to discuss America?s day-care centers and how new vaccines attribute to a safer environment.
Advertisement
(Running time: appx. 9 minutes)
This MedPage Today video features senior staff writer Michael Smith sitting down with Larry Pickering, M.D., an infectious diseases specialist at the CDC, and Janet Englund, M.D., of the University of Washington in Seattle, to discuss America?s day-care centers and how new vaccines attribute to a safer environment.
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
Advertisement
Advertisement
Trending on Patient Care Online
1
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
2
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
3
Mirikizumab Linked to Higher Rates of Corticosteroid-Free Composite Remission in UC and Crohn Disease
4
ACOG Issues Expanded Guideline on Managing Menopause-Related Vasomotor, Sleep, and Mood Symptoms
5